Last reviewed · How we verify

NCT03530826

A Crowd Sourcing Platform for Patients With Cancer

Recruiting now Last updated 30 July 2024
What this trial tests

trial testing No intervention in Cancer in 5,000 participants. Currently enrolling.

Timeline
26 April 2018
Primary endpoint
31 January 2028
31 January 2028

Quick facts

Lead sponsorAll4Cure
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment5,000
Start date26 April 2018
Primary completion31 January 2028
Estimated completion31 January 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

All4Cure

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other All4Cure trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530826.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing